CLINICAL_TRIALS
trial_result
· 2008-09-16
Clinical Trial Update: AScVS and/ or Prazosin for Scorpion Envenomation [Phase 3]
Summary
Phase 3 clinical trial update for AScVS and/or Prazosin in scorpion envenomation has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Haffkine Bio-Pharmaceutical Corporation Ltd. | Conditions: Scorpion Envenomation | Phase 3 | Status: COMPLETED